{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:25:38Z","timestamp":1791260738427,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1136\/annrheumdis-2011-200418","type":"journal-article","created":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T01:25:03Z","timestamp":1328059503000},"page":"935-942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial"],"prefix":"10.1016","volume":"71","author":[{"given":"Michael","family":"Spaeth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly A","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y Grace","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinglin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest H","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2011-200418_bib1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/ard.2003.010223","article-title":"Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries","volume":"63","author":"Woolf","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2011-200418_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.sleep.2007.07.007","article-title":"Comparison of sleep variables between chronic widespread musculoskeletal pain, insomnia, periodic leg movements syndrome and control subjects in a clinical sleep medicine practice","volume":"9","author":"Okura","year":"2008","journal-title":"Sleep Med"},{"key":"10.1136\/annrheumdis-2011-200418_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.smrv.2005.08.001","article-title":"Sleep deprivation and pain perception","volume":"10","author":"Lautenbacher","year":"2006","journal-title":"Sleep Med Rev"},{"key":"10.1136\/annrheumdis-2011-200418_bib4","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/01.psy.0000145912.24553.c0","article-title":"Sleep deprivation affects thermal pain thresholds but not somatosensory thresholds in healthy volunteers","volume":"66","author":"Kundermann","year":"2004","journal-title":"Psychosom Med"},{"key":"10.1136\/annrheumdis-2011-200418_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/sleep\/29.2.145","article-title":"Sleep loss and REM sleep loss are hyperalgesic","volume":"29","author":"Roehrs","year":"2006","journal-title":"Sleep"},{"key":"10.1136\/annrheumdis-2011-200418_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/BOR.0b013e328333b9cc","article-title":"Rheumatic manifestations of sleep disorders","volume":"22","author":"Moldofsky","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200418_bib7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200418_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/JOM.0b013e31815cff4b","article-title":"Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss","volume":"50","author":"White","year":"2008","journal-title":"J Occup Environ Med"},{"key":"10.1136\/annrheumdis-2011-200418_bib9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.semarthrit.2008.12.003","article-title":"Prevalence of fibromyalgia: a survey in five European countries","volume":"39","author":"Branco","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200418_bib10","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3899\/jrheum.090367","article-title":"Fibromyalgia syndrome module at OMERACT 9: domain construct","volume":"36","author":"Mease","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200418_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.rdc.2009.05.008","article-title":"The significance of dysfunctions of the sleeping\/waking brain to the pathogenesis and treatment of fibromyalgia syndrome","volume":"35","author":"Moldofsky","year":"2009","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/annrheumdis-2011-200418_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00006842-197507000-00008","article-title":"Musculosketal symptoms and non-REM sleep disturbance in patients with \u201cfibrositis syndrome\u201d and healthy subjects","volume":"37","author":"Moldofsky","year":"1975","journal-title":"Psychosom Med"},{"key":"10.1136\/annrheumdis-2011-200418_bib13","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/rheumatology\/ken389","article-title":"Restorative sleep predicts the resolution of chronic widespread pain: results from the EPIFUND study","volume":"47","author":"Davies","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2011-200418_bib14","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2165\/00023210-200620120-00004","article-title":"Gamma-hydroxybutyrate\/sodium oxybate: neurobiology, and impact on sleep and wakefulness","volume":"20","author":"Pardi","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1136\/annrheumdis-2011-200418_bib15","first-page":"1986","article-title":"Effect of gamma-hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fibromyalgia. Preliminary report","volume":"25","author":"Scharf","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200418_bib16","first-page":"1070","article-title":"The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia","volume":"30","author":"Scharf","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200418_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/art.24142","article-title":"Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial","volume":"60","author":"Russell","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200418_bib18","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.3899\/jrheum.091041","article-title":"Effects of sodium oxybate on sleep physiology and sleep\/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study","volume":"37","author":"Moldofsky","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200418_bib19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.pain.2010.12.022","article-title":"Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study","volume":"152","author":"Russell","year":"2011","journal-title":"Pain"},{"key":"10.1136\/annrheumdis-2011-200418_bib20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-131-7-199910050-00002","article-title":"Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome","volume":"131","author":"Netzer","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1136\/annrheumdis-2011-200418_bib21","unstructured":"Xyrem (Sodium Oxybate) Oral Solution [prescribing information]. Palo Alto, CA: Jazz Pharmaceuticals, Inc. 2007."},{"key":"10.1136\/annrheumdis-2011-200418_bib22","first-page":"728","article-title":"The fibromyalgia impact questionnaire: development and validation","volume":"18","author":"Burckhardt","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200418_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0895-4356(88)90138-2","article-title":"A scale for the estimation of sleep problems in clinical research","volume":"41","author":"Jenkins","year":"1988","journal-title":"J Clin Epidemiol"},{"issue":"6 Suppl 63","key":"10.1136\/annrheumdis-2011-200418_bib24","first-page":"S100","article-title":"Assessing sleep in fibromyalgia: investigation of an alternative scoring method for the Jenkins Sleep Scale based on data from randomized controlled studies","volume":"28","author":"Crawford","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200418_bib25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1136\/annrheumdis-2011-200418_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol \u2013 a new facility for the measurement of health-related quality of life","volume":"16","author":"The EuroQol group","year":"1990","journal-title":"Health Policy"},{"key":"10.1136\/annrheumdis-2011-200418_bib27","first-page":"835","article-title":"An instrument to measure functional status outcomes for disorders of excessive sleepiness","volume":"20","author":"Weaver","year":"1997","journal-title":"Sleep"},{"key":"10.1136\/annrheumdis-2011-200418_bib28","first-page":"377","article-title":"A standardized manual tender point survey. I. Development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome","volume":"24","author":"Okifuji","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200418_bib29","series-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1136\/annrheumdis-2011-200418_bib30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3899\/jrheum.080734","article-title":"The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Mease","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200418_bib31","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/sleep\/30.4.494","article-title":"The effects of sleep deprivation on pain inhibition and spontaneous pain in women","volume":"30","author":"Smith","year":"2007","journal-title":"Sleep"},{"key":"10.1136\/annrheumdis-2011-200418_bib32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pain.2004.12.032","article-title":"Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition","volume":"114","author":"Julien","year":"2005","journal-title":"Pain"},{"key":"10.1136\/annrheumdis-2011-200418_bib33","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3899\/jrheum.081090","article-title":"Minimal clinically important difference in the fibromyalgia impact questionnaire","volume":"36","author":"Bennett","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200418_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00019053-199915020-00003","article-title":"Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II","volume":"15","author":"Samsa","year":"1999","journal-title":"Pharmacoeconomics"},{"key":"10.1136\/annrheumdis-2011-200418_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurol"},{"key":"10.1136\/annrheumdis-2011-200418_bib36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia \u2013 responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1136\/annrheumdis-2011-200418_bib37","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.clinthera.2008.11.009","article-title":"Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial","volume":"30","author":"Clauw","year":"2008","journal-title":"Clin Ther"},{"key":"10.1136\/annrheumdis-2011-200418_bib38","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jpain.2008.03.013","article-title":"A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia","volume":"9","author":"Arnold","year":"2008","journal-title":"J Pain"},{"key":"10.1136\/annrheumdis-2011-200418_bib39","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1002\/art.20485","article-title":"A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder","volume":"50","author":"Arnold","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200418_bib40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","article-title":"A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder","volume":"119","author":"Arnold","year":"2005","journal-title":"Pain"},{"key":"10.1136\/annrheumdis-2011-200418_bib41","first-page":"502","article-title":"A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia","volume":"35","author":"Mease","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2011-200418_bib42","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.20983","article-title":"Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial","volume":"52","author":"Crofford","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2011-200418_bib43","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00482-007-0602-z","article-title":"[What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association]","volume":"22","author":"H\u00e4user","year":"2008","journal-title":"Schmerz"},{"key":"10.1136\/annrheumdis-2011-200418_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2474-8-27","article-title":"An internet survey of 2,596 people with fibromyalgia","volume":"8","author":"Bennett","year":"2007","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1136\/annrheumdis-2011-200418_bib45","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724188152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724188152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2011-200418","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T05:29:41Z","timestamp":1737350981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724188152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0003496724188152"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2011-200418","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2011-200418","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Inc. For permission to use (where not already granted under a licence) please go to http:\/\/group.bmj.com\/group\/rights-licensing\/permissions. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}